Depression Research Today is a free monthly online journal that collates and summarizes the latest research about Depression, including details on clinical depression, medication, symptoms, treatment, counselling, therapy.

Volume 7 (2010), Issue 10 (October)

1. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.
   Am J Psychiatry, 167(10): 1254-63. [Abstract] [Full-text]
2. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication.
   Am J Psychiatry, 167(10): 1194-201. [Abstract] [Full-text]
3. The factor structure of the Hospital Anxiety and Depression Scale in individuals with traumatic brain injury.
   Psychiatry Res, 179(3): 342-9. [Abstract] [Full-text]
4. Evaluation of the linköping youth life experience scale.
   J Nerv Ment Dis, 198(10): 768-74. [Abstract] [Full-text]
5. Clinical characteristics of depressed patients with a history of suicide attempts: results from the CRESCEND study in South Korea.
   J Nerv Ment Dis, 198(10): 748-54. [Abstract] [Full-text]
6. Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder.
   Arch Gen Psychiatry, 67(10): 1044-51. [Abstract] [Full-text]
7. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.
   Arch Gen Psychiatry, 67(10): 1012-24. [Abstract] [Full-text]
8. Regional brain volume in depression and anxiety disorders.
   Arch Gen Psychiatry, 67(10): 1002-11. [Abstract] [Full-text]
9. Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES]).
   Am J Cardiol, 106(8): 1104-7. [Abstract] [Full-text]
10. Kangaroo care on premature infant growth and maternal attachment and post-partum depression in South Korea.
    J Trop Pediatr, 56(5): 342-4. [Abstract] [Full-text]
11. Overnight changes of immune parameters and catecholamines are associated with mood and stress.
    Psychosom Med, 72(8): 755-62. [Abstract] [Full-text]
12. Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.
    Psychosom Med, 72(8): 748-54. [Abstract] [Full-text]
13. Dietary folate, riboflavin, vitamin B-6, and vitamin B-12 and depressive symptoms in early adolescence: the Ryukyus Child Health Study.
    Psychosom Med, 72(8): 763-8. [Abstract] [Full-text]
14. Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Psychosom Med, 72(8): 734-41. [Abstract] [Full-text]
15. Maternal depressive symptoms in relation to perinatal mortality and morbidity: results from a large multiethnic cohort study.
    Psychosom Med, 72(8): 769-76. [Abstract] [Full-text]
16. Recurrent major depression predicts progression of coronary calcification in healthy women: Study of Women's Health Across the Nation.
    Psychosom Med, 72(8): 742-7. [Abstract] [Full-text]
17. Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis.
    Chest, 138(4): 929-36. [Abstract] [Full-text]
18. Relationship between physical functioning and physical activity in the lifestyle interventions and independence for elders pilot.
    J Am Geriatr Soc, 58(10): 1918-24. [Abstract] [Full-text]
19. Effect of pathological use of the internet on adolescent mental health: a prospective study.
    Arch Pediatr Adolesc Med, 164(10): 901-6. [Abstract] [Full-text]
20. The effects of anger and sadness on clinical pain reports and experimentally-induced pain thresholds in women with and without fibromyalgia.
    Arthritis Care Res (Hoboken), 62(10): 1370-6. [Abstract] [Full-text]
21. Body mass index and attempted suicide: Cohort study of 1,133,019 Swedish men.
    Am J Epidemiol, 172(8): 890-9. [Abstract] [Full-text]
22. Invited commentary: Body mass index and suicide--untangling an unlikely association.
    Am J Epidemiol, 172(8): 900-4; discussion 905-6. [Abstract] [Full-text]
23. Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use.
    Arch Intern Med, 170(18): 1686-94. [Abstract] [Full-text]
24. How to prescribe hemodialysis or hemodiafiltration in order to ameliorate dialysis-related symptoms and complications.
    Contrib Nephrol, 168: 53-63. [Abstract] [Full-text]
25. Co-morbid anxiety and depression among pulmonary tuberculosis patients.
    J Coll Physicians Surg Pak, 20(10): 703-4. [Abstract] [Full-text]
26. Not saying I am happy does not mean I am not: cultural influences on responses to positive affect items in the CES-D.
    J Gerontol B Psychol Sci Soc Sci, 65(6): 684-90. [Abstract] [Full-text]
27. Not saying I am happy does not mean I am not: cultural influences on responses to positive affect items in the CES-D.
    J Gerontol B Psychol Sci Soc Sci, 65(6): 684-90. [Abstract] [Full-text]
28. Obesity might not be a risk factor for female sexual dysfunction.
    BJU Int, 106(9): 1357-61. [Abstract] [Full-text]
29. An approach to the patient with dysregulated mood: major depression and bipolar disorder.
    Med Clin North Am, 94(6): 1117-26, x. [Abstract] [Full-text]
30. Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression.
    Acta Oncol, 49(8): 1235-45. [Abstract] [Full-text]
31. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
    Clin Pharmacol Ther, 88(5): 592-4. [Abstract] [Full-text]
32. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.
    JAMA, 304(15): 1675-83. [Abstract] [Full-text]
33. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Clin Pharmacol Ther, 88(5): 634-42. [Abstract] [Full-text]
34. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
    Clin Pharmacol Ther, 88(5): 592-4. [Abstract] [Full-text]
35. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Clin Pharmacol Ther, 88(5): 634-42. [Abstract] [Full-text]
36. Emotional eating and physical activity self-efficacy as pathways in the association between depressive symptoms and adiposity indicators.
    Am J Clin Nutr, 92(5): 1031-9. [Abstract] [Full-text]
37. Psychosocial impact of visual impairment in working-age adults.
    Br J Ophthalmol, 94(11): 1427-31. [Abstract] [Full-text]
38. Emotional eating and physical activity self-efficacy as pathways in the association between depressive symptoms and adiposity indicators.
    Am J Clin Nutr, 92(5): 1031-9. [Abstract] [Full-text]
39. Psychosocial impact of visual impairment in working-age adults.
    Br J Ophthalmol, 94(11): 1427-31. [Abstract] [Full-text]
40. Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample.
    Obstet Gynecol, 116(5): 1064-70. [Abstract] [Full-text]
41. Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample.
    Obstet Gynecol, 116(5): 1064-70. [Abstract] [Full-text]
42. MR imaging of psychosurgery: rostral atrophy following stereotacic subcaudate tractotomy.
    Br J Radiol, 83(995): e239-42. [Abstract] [Full-text]
43. TAAR6 variations possibly associated with antidepressant response and suicidal behavior.
    Psychiatry Res, 180(1): 20-4. [Abstract] [Full-text]
44. Predictive relationship between depression and physical functioning after coronary surgery.
    Arch Intern Med, 170(19): 1717-21. [Abstract] [Full-text]
45. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
    Med Care, 48(11): 947-54. [Abstract] [Full-text]
46. Predictive relationship between depression and physical functioning after coronary surgery.
    Arch Intern Med, 170(19): 1717-21. [Abstract] [Full-text]
47. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
    Med Care, 48(11): 947-54. [Abstract] [Full-text]

© 2004-2012 Depression Research Today. All Rights Reserved.